| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.855 | 0.004 | 0.855 | Hypoglycemic | 0.468 0.018 CID_26295 | ||
| 0.669 | 0.006 | 0.669 | Immunosuppressant | 0.232 0.164 CID_26295 | ||
| 0.525 | 0.004 | 0.525 | Calcium channel activator | 0.44 0.013 CID_26295 | ||
| 0.405 | 0.048 | 0.405 | Immunostimulant | 0.284 0.083 CID_26295 | ||
| 0.415 | 0.083 | 0.553 | Cyclophilin D inhibitor | 0.553 0.037 CID_26295 | CID_26295 | |
| 0.313 | 0.005 | 0.313 | Estrogen agonist | 0.061 0.03 CID_26295 | ||
| 0.316 | 0.081 | 0.651 | Cholesterol antagonist | 0.651 0.012 CID_26295 | CID_26295 | |
| 0.326 | 0.099 | 0.335 | Calpain 2 inhibitor | 0.335 0.094 CID_26295 | CID_26295 | |
| 0.219 | 0.004 | 0.219 | Neuraminidase inhibitor | |||
| 0.234 | 0.035 | 0.234 | 3C-like protease (Human coronavirus) inhibitor | 0.186 0.06 CID_26295 | ||
| 0.106 | 0.017 | 0.106 | Elastase 1 inhibitor | |||
| 0.214 | 0.126 | 0.52 | 5 Hydroxytryptamine uptake stimulant | 0.52 0.004 CID_26295 | CID_26295 | |
| 0.168 | 0.083 | 0.351 | Succinate dehydrogenase inhibitor | 0.351 0.005 CID_26295 | CID_26295 | |
| 0.152 | 0.067 | 0.365 | Protein kinase stimulant | 0.365 0.011 CID_26295 | CID_26295 | |
| 0.106 | 0.022 | 0.106 | Calcium channel L-type blocker | |||
| 0.222 | 0.159 | 0.374 | Sodium/bile acid cotransporter inhibitor | 0.374 0.027 CID_26295 | CID_26295 | |
| 0.128 | 0.069 | 0.191 | Cyclooxygenase 3 inhibitor | 0.191 0.022 CID_26295 | CID_26295 | |
| 0.057 | 0.004 | 0.057 | Elastase 3A inhibitor | 0.029 0.026 CID_26295 | ||
| 0.057 | 0.004 | 0.057 | Elastase 3B inhibitor | 0.029 0.026 CID_26295 | ||
| 0.057 | 0.004 | 0.057 | Elastase 2B inhibitor | 0.029 0.026 CID_26295 | ||
| 0.073 | 0.022 | 0.077 | Heme oxygenase stimulant | 0.077 0.017 CID_26295 | CID_26295 | |
| 0.115 | 0.065 | 0.122 | Estrogen antagonist | 0.122 0.051 CID_26295 | CID_26295 | |
| 0.179 | 0.136 | 0.224 | Calpain inhibitor | 0.224 0.091 CID_26295 | CID_26295 | |
| 0.109 | 0.076 | 0.175 | Cholesterol synthesis inhibitor | 0.175 0.034 CID_26295 | CID_26295 | |
| 0.146 | 0.114 | 0.218 | Hepatoprotectant | 0.218 0.055 CID_26295 | CID_26295 | |
| 0.21 | 0.179 | 0.21 | Beta lactamase inhibitor | |||
| 0.133 | 0.105 | 0.243 | Interferon gamma antagonist | 0.243 0.03 CID_26295 | CID_26295 | |
| 0.064 | 0.036 | 0.064 | Androgen agonist | 0.059 0.042 CID_26295 | ||
| 0.114 | 0.094 | 0.114 | Calcium channel blocker | |||
| 0.131 | 0.118 | 0.164 | Heat shock protein 70 antagonist | 0.164 0.023 CID_26295 | CID_26295 | |
| 0.097 | 0.088 | 0.097 | Calcium channel (voltage-sensitive) blocker | |||
| 0.088 | 0.079 | 0.137 | Bile acid receptor antagonist | 0.137 0.01 CID_26295 | CID_26295 | |
| 0.129 | 0.121 | 0.217 | Nitric oxide antagonist | 0.217 0.062 CID_26295 | CID_26295 | |
| 0.033 | 0.025 | 0.108 | Free fatty acid receptor 1 antagonist | 0.108 0.003 CID_26295 | CID_26295 | |
| 0.063 | 0.057 | 0.116 | Glutamate (mGluR6) antagonist | 0.116 0.006 CID_26295 | CID_26295 | |
| 0.145 | 0.14 | 0.276 | Insulin sensitizer | 0.276 0.022 CID_26295 | CID_26295 | |
| 0.044 | 0.041 | 0.085 | Cholesterol esterase inhibitor | 0.085 0.005 CID_26295 | CID_26295 | |
| 0.095 | 0.094 | 0.169 | Electron transport complex I inhibitor | 0.169 0.013 CID_26295 | CID_26295 | |
| 0.038 | 0.037 | 0.076 | Guanylate cyclase inhibitor | 0.076 0.004 CID_26295 | CID_26295 | |
| 0.128 | 0.131 | 0.172 | Ca2+-transporting ATPase inhibitor | 0.172 0.012 CID_26295 | CID_26295 | |
| 0.082 | 0.085 | 0.172 | Glutamate release inhibitor | 0.172 0.006 CID_26295 | CID_26295 | |
| 0.12 | 0.126 | 0.204 | Arachidonic acid antagonist | 0.204 0.029 CID_26295 | CID_26295 | |
| 0.175 | 0.188 | 0.361 | Tyrosine 3 hydroxylase inhibitor | 0.361 0.014 CID_26295 | CID_26295 | |
| 0.027 | 0.042 | 0.059 | Farnesoid X receptor agonist | 0.059 0.01 CID_26295 | CID_26295 | |
| 0.042 | 0.057 | 0.084 | Squalene epoxidase inhibitor | 0.084 0.008 CID_26295 | CID_26295 | |
| 0.072 | 0.093 | 0.164 | Transcription factor NF kappa B stimulant | 0.164 0.013 CID_26295 | CID_26295 | |
| 0.008 | 0.031 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | 0.012 0.01 CID_26295 | CID_26295 | |
| 0.041 | 0.068 | 0.13 | Sodium/calcium exchanger inhibitor | 0.13 0.004 CID_26295 | CID_26295 | |
| 0.142 | 0.172 | 0.395 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.395 0.008 CID_26295 | CID_26295 | |
| 0.015 | 0.045 | 0.032 | Squalene synthetase inhibitor | 0.032 0.022 CID_26295 | CID_26295 | |
| 0.07 | 0.101 | 0.341 | Triose-phosphate isomerase inhibitor | 0.341 0.004 CID_26295 | CID_26295 | |
| 0.127 | 0.162 | 0.464 | Phospholipase C inhibitor | 0.464 0.007 CID_26295 | CID_26295 | |
| 0.103 | 0.137 | 0.172 | Vanilloid 1 agonist | 0.172 0.022 CID_26295 | CID_26295 | |
| 0.021 | 0.055 | 0.061 | Retinoid X alpha receptor agonist | 0.061 0.011 CID_26295 | CID_26295 | |
| 0.04 | 0.081 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | 0.054 0.035 CID_26295 | CID_26295 | |
| 0.013 | 0.055 | 0.034 | Lysophosphatidic acid 1 receptor antagonist | 0.034 0.005 CID_26295 | CID_26295 | |
| 0.056 | 0.101 | 0.101 | Peroxisome proliferator-activated receptor gamma antagonist | 0.101 0.015 CID_26295 | CID_26295 | |
| 0.005 | 0.051 | 0.034 | Peroxisome proliferator-activated receptor alpha antagonist | 0.034 0.01 CID_26295 | CID_26295 | |
| 0.075 | 0.122 | 0.111 | DNA polymerase I inhibitor | 0.111 0.076 CID_26295 | CID_26295 | |
| 0.059 | 0.108 | 0.097 | Estrogen receptor alpha antagonist | 0.097 0.029 CID_26295 | CID_26295 | |
| 0.038 | 0.088 | 0.154 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.154 0.006 CID_26295 | CID_26295 | |
| 0.245 | 0.296 | 0.46 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.46 0.055 CID_26295 | CID_26295 | |
| 0.066 | 0.117 | 0.319 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.319 0.005 CID_26295 | CID_26295 | |
| 0.026 | 0.077 | 0.048 | Leukocyte elastase inhibitor | 0.048 0.025 CID_26295 | CID_26295 | |
| 0.006 | 0.058 | 0.066 | Free fatty acid receptor 1 agonist | 0.066 0.004 CID_26295 | CID_26295 | |
| 0.011 | 0.065 | 0.104 | Uridine phosphorylase inhibitor | 0.104 0.002 CID_26295 | CID_26295 | |
| 0.108 | 0.164 | 0.226 | Melanin inhibitor | 0.226 0.033 CID_26295 | CID_26295 | |
| 0.078 | 0.135 | 0.204 | DOPA decarboxylase inhibitor | 0.204 0.006 CID_26295 | CID_26295 | |
| 0.206 | 0.264 | 0.528 | Calcium channel L-type activator | 0.528 0.018 CID_26295 | CID_26295 | |
| 0.043 | 0.102 | 0.105 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 CID_26295 | CID_26295 | |
| 0.034 | 0.093 | 0.086 | Leukotriene B4 antagonist | 0.086 0.013 CID_26295 | CID_26295 | |
| 0.014 | 0.074 | 0.049 | Retinoid X receptor agonist | 0.049 0.018 CID_26295 | CID_26295 | |
| 0.013 | 0.073 | 0.119 | Liver X receptor beta antagonist | 0.119 0.003 CID_26295 | CID_26295 | |
| 0.022 | 0.084 | 0.052 | GABA uptake inhibitor | 0.052 0.014 CID_26295 | CID_26295 | |
| 0.051 | 0.114 | 0.12 | Androgen antagonist | 0.12 0.033 CID_26295 | CID_26295 | |
| 0.004 | 0.066 | 0.026 | Prostaglandin EP4 agonist | 0.026 0.008 CID_26295 | CID_26295 | |
| 0.004 | 0.068 | 0.048 | G-protein-coupled receptor 120 agonist | 0.048 0.004 CID_26295 | CID_26295 | |
| 0.043 | 0.108 | 0.086 | Protease 3C (Human rhinovirus) inhibitor | 0.086 0.023 CID_26295 | CID_26295 | |
| 0.067 | 0.132 | 0.102 | Estrogen receptor beta antagonist | 0.102 0.061 CID_26295 | CID_26295 | |
| 0.053 | 0.118 | 0.191 | Keratolytic | 0.191 0.009 CID_26295 | CID_26295 | |
| 0.003 | 0.068 | 0.011 | Thromboxane agonist | 0.011 0.007 CID_26295 | CID_26295 | |
| 0.017 | 0.082 | 0.045 | ATP citrate lysase inhibitor | 0.045 0.01 CID_26295 | CID_26295 | |
| 0.106 | 0.173 | 0.203 | Sphingosine 1-phosphate receptor 5 antagonist | 0.203 0.01 CID_26295 | CID_26295 | |
| 0.121 | 0.189 | 0.429 | Neurotrophic factor enhancer | 0.429 0.005 CID_26295 | CID_26295 | |
| 0.007 | 0.076 | 0.04 | Prostaglandin E2 agonist | 0.04 0.007 CID_26295 | CID_26295 | |
| 0.066 | 0.135 | 0.141 | Anabolic | 0.141 0.023 CID_26295 | CID_26295 | |
| 0.008 | 0.078 | 0.02 | Thyroid hormone alpha agonist | 0.02 0.007 CID_26295 | CID_26295 | |
| 0.007 | 0.077 | 0.031 | Thyroid hormone alpha antagonist | 0.031 0.005 CID_26295 | CID_26295 | |
| 0.048 | 0.12 | 0.135 | Ornithine decarboxylase inhibitor | 0.135 0.017 CID_26295 | CID_26295 | |
| 0.019 | 0.091 | 0.085 | Peroxisome proliferator-activated receptor alpha agonist | 0.085 0.016 CID_26295 | CID_26295 | |
| 0.008 | 0.081 | 0.02 | Telomerase stimulant | 0.02 0.008 CID_26295 | CID_26295 | |
| 0.011 | 0.085 | 0.029 | Isoleucine-tRNA ligase inhibitor | 0.029 0.006 CID_26295 | CID_26295 | |
| 0.012 | 0.087 | 0.053 | Prostaglandin agonist | 0.053 0.009 CID_26295 | CID_26295 | |
| 0.043 | 0.12 | 0.075 | Leukotriene C antagonist | 0.075 0.01 CID_26295 | CID_26295 | |
| 0.014 | 0.091 | 0.034 | Vanilloid 2 agonist | 0.034 0.006 CID_26295 | CID_26295 | |
| 0.064 | 0.141 | 0.274 | Cystathionine beta-synthase inhibitor | 0.274 0.012 CID_26295 | CID_26295 | |
| 0.007 | 0.085 | 0.039 | Prostaglandin EP2 agonist | 0.039 0.009 CID_26295 | CID_26295 | |
| 0.02 | 0.101 | 0.04 | Glutamate (mGluR3) agonist | 0.04 0.01 CID_26295 | CID_26295 | |
| 0.042 | 0.122 | 0.07 | Nicotinic alpha4beta2 receptor antagonist | 0.07 0.061 CID_26295 | CID_26295 | |
| 0.028 | 0.109 | 0.052 | Leukotriene C4 antagonist | 0.052 0.009 CID_26295 | CID_26295 | |
| 0.007 | 0.09 | 0.019 | Purinergic P2Y1 agonist | 0.019 0.007 CID_26295 | CID_26295 | |
| 0.062 | 0.145 | 0.158 | Granulocyte macrophage colony stimulating factor agonist | 0.158 0.005 CID_26295 | CID_26295 | |
| 0.008 | 0.092 | 0.04 | Prostaglandin EP3 antagonist | 0.04 0.014 CID_26295 | CID_26295 | |
| 0.086 | 0.17 | 0.197 | Sphingosine 1-phosphate receptor 4 antagonist | 0.197 0.009 CID_26295 | CID_26295 | |
| 0.037 | 0.122 | 0.125 | Purinergic P2X1 antagonist | 0.125 0.01 CID_26295 | CID_26295 | |
| 0.062 | 0.148 | 0.115 | ABCA1 expression enhancer | 0.115 0.034 CID_26295 | CID_26295 | |
| 0.074 | 0.16 | 0.175 | Photosensitizer | 0.175 0.02 CID_26295 | CID_26295 | |
| 0.012 | 0.097 | 0.039 | 5-Alpha-reductase inhibitor | 0.039 0.024 CID_26295 | CID_26295 | |
| 0.019 | 0.105 | 0.069 | Glutamate (mGluR3) antagonist | 0.069 0.006 CID_26295 | CID_26295 | |
| 0.064 | 0.15 | 0.129 | Estrogen-related receptor beta agonist | 0.129 0.007 CID_26295 | CID_26295 | |
| 0.013 | 0.1 | 0.078 | Liver X receptor alpha antagonist | 0.078 0.004 CID_26295 | CID_26295 | |
| 0.054 | 0.141 | 0.342 | HIV-1 integrase (Overall Integration) inhibitor | 0.342 0.003 CID_26295 | CID_26295 | |
| 0.011 | 0.1 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.013 CID_26295 | CID_26295 | |
| 0.046 | 0.136 | 0.268 | Monophenol monooxygenase inhibitor | 0.268 0.022 CID_26295 | CID_26295 | |
| 0.025 | 0.115 | 0.097 | Lysophosphatidic acid 3 receptor antagonist | 0.097 0.005 CID_26295 | CID_26295 | |
| 0.01 | 0.102 | 0.056 | Prostaglandin EP4 antagonist | 0.056 0.007 CID_26295 | CID_26295 | |
| 0.039 | 0.131 | 0.147 | Cathepsin G inhibitor | 0.147 0.021 CID_26295 | CID_26295 | |
| 0.097 | 0.19 | 0.202 | Adenylate cyclase stimulant | 0.202 0.013 CID_26295 | CID_26295 | |
| 0.068 | 0.161 | 0.145 | Microtubule formation inhibitor | 0.145 0.04 CID_26295 | CID_26295 | |
| 0.01 | 0.106 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_26295 | CID_26295 | |
| 0.025 | 0.124 | 0.053 | Prolyl endopeptidase inhibitor | 0.053 0.032 CID_26295 | CID_26295 | |
| 0.037 | 0.138 | 0.055 | Pregnane X receptor antagonist | 0.055 0.045 CID_26295 | CID_26295 | |
| 0.061 | 0.163 | 0.093 | Vanilloid agonist | 0.093 0.043 CID_26295 | CID_26295 | |
| 0.026 | 0.128 | 0.176 | Selectin antagonist | 0.176 0.014 CID_26295 | CID_26295 | |
| 0.088 | 0.191 | 0.201 | Farnesoid X receptor antagonist | 0.201 0.021 CID_26295 | CID_26295 | |
| 0.03 | 0.133 | 0.063 | Glucose-6-phosphate translocase inhibitor | 0.063 0.021 CID_26295 | CID_26295 | |
| 0.009 | 0.113 | 0.027 | Leukotriene B4 receptor 2 antagonist | 0.027 0.01 CID_26295 | CID_26295 | |
| 0.036 | 0.144 | 0.171 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.171 0.014 CID_26295 | CID_26295 | |
| 0.002 | 0.111 | 0.017 | Thyroid hormone beta agonist | 0.017 0.004 CID_26295 | CID_26295 | |
| 0.042 | 0.152 | 0.068 | CDC25A inhibitor | 0.068 0.061 CID_26295 | CID_26295 | |
| 0.008 | 0.12 | 0.223 | Leukotriene A4 hydrolase inhibitor | 0.223 0.004 CID_26295 | CID_26295 | |
| 0.003 | 0.115 | 0.012 | Glutamate (mGluR6) agonist | 0.012 0.008 CID_26295 | CID_26295 | |
| 0.065 | 0.18 | 0.523 | Alpha-N-acetylglucosaminidase inhibitor | 0.523 0.005 CID_26295 | CID_26295 | |
| 0.012 | 0.128 | 0.057 | Thyroid hormone agonist | 0.057 0.004 CID_26295 | CID_26295 | |
| 0.058 | 0.175 | 0.202 | Xanthine oxidase inhibitor | 0.202 0.019 CID_26295 | CID_26295 | |
| 0.01 | 0.127 | 0.074 | Peroxisome proliferator-activated receptor delta agonist | 0.074 0.008 CID_26295 | CID_26295 | |
| 0.07 | 0.189 | 0.156 | Cathepsin H inhibitor | 0.156 0.042 CID_26295 | CID_26295 | |
| 0.043 | 0.163 | 0.089 | Exportin-1 inhibitor | 0.089 0.015 CID_26295 | CID_26295 | |
| 0.019 | 0.139 | 0.156 | Liver X receptor alpha agonist | 0.156 0.004 CID_26295 | CID_26295 | |
| 0.026 | 0.148 | 0.103 | Leukotriene antagonist | 0.103 0.02 CID_26295 | CID_26295 | |
| 0.039 | 0.161 | 0.06 | Caspase 9 inhibitor | 0.06 0.046 CID_26295 | CID_26295 | |
| 0.025 | 0.149 | 0.1 | Aconitate hydratase inhibitor | 0.1 0.008 CID_26295 | CID_26295 | |
| 0.067 | 0.193 | 0.122 | TRPA1 agonist | 0.122 0.056 CID_26295 | CID_26295 | |
| 0.037 | 0.163 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.026 CID_26295 | CID_26295 | |
| 0.203 | 0.33 | 0.475 | Antiinflammatory | 0.475 0.098 CID_26295 | CID_26295 | |
| 0.043 | 0.17 | 0.093 | Glycine receptor agonist | 0.093 0.025 CID_26295 | CID_26295 | |
| 0.033 | 0.162 | 0.061 | Potassium channel intermediate-conductance Ca-activated blocker | 0.061 0.039 CID_26295 | CID_26295 | |
| 0.01 | 0.139 | 0.07 | Sodium/glucose cotransporter inhibitor | 0.07 0.004 CID_26295 | CID_26295 | |
| 0.014 | 0.143 | 0.113 | Phosphorylase inhibitor | 0.113 0.011 CID_26295 | CID_26295 | |
| 0.004 | 0.134 | 0.021 | Prostaglandin EP1 antagonist | 0.021 0.013 CID_26295 | CID_26295 | |
| 0.025 | 0.155 | 0.097 | Glucose-6-phosphate isomerase inhibitor | 0.097 0.005 CID_26295 | CID_26295 | |
| 0.035 | 0.165 | 0.08 | Calcium antagonist | 0.08 0.064 CID_26295 | CID_26295 | |
| 0.016 | 0.147 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.033 0.008 CID_26295 | CID_26295 | |
| 0.009 | 0.14 | 0.035 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.035 0.019 CID_26295 | CID_26295 | |
| 0.013 | 0.145 | 0.038 | Estrogen-related receptor alpha antagonist | 0.038 0.018 CID_26295 | CID_26295 | |
| 0.01 | 0.143 | 0.021 | Factor XIII inhibitor | 0.021 0.014 CID_26295 | CID_26295 | |
| 0.071 | 0.205 | 0.288 | Angiogenesis stimulant | 0.288 0.054 CID_26295 | CID_26295 | |
| 0.055 | 0.189 | 0.49 | Amylase inhibitor | 0.49 0.006 CID_26295 | CID_26295 | |
| 0.094 | 0.229 | 0.244 | CF transmembrane conductance regulator agonist | 0.244 0.007 CID_26295 | CID_26295 | |
| 0.017 | 0.153 | 0.046 | Glutamate (mGluR5) agonist | 0.046 0.032 CID_26295 | CID_26295 | |
| 0.011 | 0.147 | 0.132 | Liver X receptor beta agonist | 0.132 0.004 CID_26295 | CID_26295 | |
| 0.016 | 0.152 | 0.102 | Prostaglandin EP2 antagonist | 0.102 0.018 CID_26295 | CID_26295 | |
| 0.017 | 0.154 | 0.055 | Melatonin receptor 1A agonist | 0.055 0.006 CID_26295 | CID_26295 | |
| 0.126 | 0.264 | 0.282 | Gastrin inhibitor | 0.282 0.047 CID_26295 | CID_26295 | |
| 0.065 | 0.203 | 0.227 | Toll-Like receptor 2 antagonist | 0.227 0.014 CID_26295 | CID_26295 | |
| 0.095 | 0.235 | 0.165 | Death-associated protein kinase 1 inhibitor | 0.165 0.022 CID_26295 | CID_26295 | |
| 0.014 | 0.154 | 0.05 | Peroxisome proliferator-activated receptor delta antagonist | 0.05 0.009 CID_26295 | CID_26295 | |
| 0.02 | 0.161 | 0.053 | Glutamate (mGluR8) agonist | 0.053 0.01 CID_26295 | CID_26295 | |
| 0.059 | 0.2 | 0.166 | Toll-Like receptor 3 antagonist | 0.166 0.011 CID_26295 | CID_26295 | |
| 0.01 | 0.152 | 0.086 | Liver X receptor antagonist | 0.086 0.005 CID_26295 | CID_26295 | |
| 0.017 | 0.16 | 0.061 | Dihydroorotate dehydrogenase inhibitor | 0.061 0.028 CID_26295 | CID_26295 | |
| 0.055 | 0.199 | 0.205 | Nav1.6 sodium channel blocker | 0.205 0.017 CID_26295 | CID_26295 | |
| 0.026 | 0.17 | 0.067 | CF transmembrane conductance regulator antagonist | 0.067 0.004 CID_26295 | CID_26295 | |
| 0.011 | 0.156 | 0.061 | Estradiol 17 beta-dehydrogenase inhibitor | 0.061 0.019 CID_26295 | CID_26295 | |
| 0.015 | 0.161 | 0.069 | Ceramide glucosyltransferase inhibitor | 0.069 0.003 CID_26295 | CID_26295 | |
| 0.011 | 0.16 | 0.062 | Sphingosine 1-phosphate receptor 1 agonist | 0.062 0.012 CID_26295 | CID_26295 | |
| 0.036 | 0.186 | 0.116 | GABA aminotransferase inhibitor | 0.116 0.018 CID_26295 | CID_26295 | |
| 0.018 | 0.17 | 0.031 | Thiazolidinedione | 0.031 0.017 CID_26295 | CID_26295 | |
| 0.046 | 0.199 | 0.339 | UDP-glucose 4-epimerase inhibitor | 0.339 0.008 CID_26295 | CID_26295 | |
| 0.029 | 0.182 | 0.078 | Dihydroorotate oxidase inhibitor | 0.078 0.011 CID_26295 | CID_26295 | |
| 0.024 | 0.177 | 0.063 | HIV-1 integrase (3'-Processing) inhibitor | 0.063 0.044 CID_26295 | CID_26295 | |
| 0.01 | 0.163 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 CID_26295 | CID_26295 | |
| 0.006 | 0.159 | 0.027 | Leukotriene B4 receptor 1 antagonist | 0.027 0.02 CID_26295 | CID_26295 | |
| 0.009 | 0.163 | 0.026 | Nicotinic acid receptor 2 antagonist | 0.026 0.019 CID_26295 | CID_26295 | |
| 0.024 | 0.18 | 0.158 | Catalase inhibitor | 0.158 0.024 CID_26295 | CID_26295 | |
| 0.02 | 0.177 | 0.13 | Peroxisome proliferator-activated receptor gamma agonist | 0.13 0.018 CID_26295 | CID_26295 | |
| 0.028 | 0.187 | 0.052 | Heme oxygenase inhibitor | 0.052 0.011 CID_26295 | CID_26295 | |
| 0.115 | 0.275 | 0.388 | Transcription factor NF kappa B inhibitor | 0.388 0.066 CID_26295 | CID_26295 | |
| 0.011 | 0.172 | 0.042 | ICAM 1 antagonist | 0.042 0.004 CID_26295 | CID_26295 | |
| 0.041 | 0.204 | 0.21 | Sphingomyelinase inhibitor | 0.21 0.008 CID_26295 | CID_26295 | |
| 0.035 | 0.199 | 0.168 | Protein-tyrosine phosphatase 1B inhibitor | 0.168 0.039 CID_26295 | CID_26295 | |
| 0.022 | 0.187 | 0.044 | Kainate receptor agonist | 0.044 0.023 CID_26295 | CID_26295 | |
| 0.041 | 0.207 | 0.072 | Chymotrypsin inhibitor | 0.072 0.067 CID_26295 | CID_26295 | |
| 0.011 | 0.178 | 0.144 | Carbonic anhydrase VB inhibitor | 0.144 0.009 CID_26295 | CID_26295 | |
| 0.017 | 0.186 | 0.052 | HIV-1 integrase (Strand Transfer) inhibitor | 0.052 0.048 CID_26295 | CID_26295 | |
| 0.041 | 0.211 | 0.188 | Prolactin inhibitor | 0.188 0.011 CID_26295 | CID_26295 | |
| 0.034 | 0.204 | 0.153 | Anesthetic local | 0.153 0.048 CID_26295 | CID_26295 | |
| 0.033 | 0.204 | 0.109 | Glutamate (mGluR7) antagonist | 0.109 0.007 CID_26295 | CID_26295 | |
| 0.007 | 0.179 | 0.08 | Sodium/glucose cotransporter 2 inhibitor | 0.08 0.004 CID_26295 | CID_26295 | |
| 0.011 | 0.184 | 0.05 | Glutamate (mGluR group I) agonist | 0.05 0.031 CID_26295 | CID_26295 | |
| 0.013 | 0.187 | 0.051 | Potassium channel Kv1.3 blocker | 0.051 0.028 CID_26295 | CID_26295 | |
| 0.093 | 0.268 | 0.338 | Antioxidant | 0.338 0.049 CID_26295 | CID_26295 | |
| 0.019 | 0.195 | 0.117 | Biliverdin reductase inhibitor | 0.117 0.014 CID_26295 | CID_26295 | |
| 0.021 | 0.2 | 0.055 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.055 0.01 CID_26295 | CID_26295 | |
| 0.016 | 0.196 | 0.098 | Acyl-CoA dehydrogenase inhibitor | 0.098 0.017 CID_26295 | CID_26295 | |
| 0.018 | 0.2 | 0.18 | Phosphofructokinase-1 inhibitor | 0.18 0.013 CID_26295 | CID_26295 | |
| 0.177 | 0.359 | 0.593 | Caspase 9 stimulant | 0.593 0.037 CID_26295 | CID_26295 | |
| 0.009 | 0.192 | 0.051 | Cholesterol ester transfer protein antagonist | 0.051 0.006 CID_26295 | CID_26295 | |
| 0.032 | 0.215 | 0.225 | Macrophage migration inhibitory factor inhibitor | 0.225 0.006 CID_26295 | CID_26295 | |
| 0.015 | 0.198 | 0.065 | Sphingosine 1-phosphate receptor agonist | 0.065 0.013 CID_26295 | CID_26295 | |
| 0.033 | 0.218 | 0.094 | Glycine receptor antagonist | 0.094 0.039 CID_26295 | CID_26295 | |
| 0.052 | 0.238 | 0.157 | Nav1.1 sodium channel blocker | 0.157 0.03 CID_26295 | CID_26295 | |
| 0.022 | 0.21 | 0.148 | Leukotriene synthesis inhibitor | 0.148 0.009 CID_26295 | CID_26295 | |
| 0.1 | 0.288 | 0.354 | Lipoxygenase inhibitor | 0.354 0.049 CID_26295 | CID_26295 | |
| 0.047 | 0.236 | 0.277 | Carbonic anhydrase III inhibitor | 0.277 0.007 CID_26295 | CID_26295 | |
| 0.032 | 0.221 | 0.08 | Bcl2 antagonist | 0.08 0.032 CID_26295 | CID_26295 | |
| 0.019 | 0.208 | 0.096 | Alpha-mannosidase inhibitor | 0.096 0.007 CID_26295 | CID_26295 | |
| 0.046 | 0.235 | 0.213 | NADH dehydrogenase inhibitor | 0.213 0.009 CID_26295 | CID_26295 | |
| 0.02 | 0.211 | 0.046 | VCAM antagonist | 0.046 0.012 CID_26295 | CID_26295 | |
| 0.015 | 0.207 | 0.102 | Plasminogen activator inhibitor antagonist | 0.102 0.01 CID_26295 | CID_26295 | |
| 0.024 | 0.217 | 0.112 | Topoisomerase II beta inhibitor | 0.112 0.008 CID_26295 | CID_26295 | |
| 0.012 | 0.206 | 0.134 | Prostaglandin E2 antagonist | 0.134 0.01 CID_26295 | CID_26295 | |
| 0.052 | 0.246 | 0.323 | Carbonic anhydrase XV inhibitor | 0.323 0.006 CID_26295 | CID_26295 | |
| 0.02 | 0.214 | 0.047 | VCAM-1 antagonist | 0.047 0.012 CID_26295 | CID_26295 | |
| 0.013 | 0.208 | 0.109 | Xanthine dehydrogenase inhibitor | 0.109 0.013 CID_26295 | CID_26295 | |
| 0.008 | 0.206 | 0.049 | Fumarate hydratase inhibitor | 0.049 0.014 CID_26295 | CID_26295 | |
| 0.023 | 0.223 | 0.071 | Heparanase inhibitor | 0.071 0.011 CID_26295 | CID_26295 | |
| 0.017 | 0.218 | 0.047 | Benzodiazepine antagonist | 0.047 0.034 CID_26295 | CID_26295 | |
| 0.042 | 0.244 | 0.078 | Calcium channel P-type blocker | 0.078 0.017 CID_26295 | CID_26295 | |
| 0.035 | 0.238 | 0.234 | Carbonic anhydrase VI inhibitor | 0.234 0.01 CID_26295 | CID_26295 | |
| 0.051 | 0.254 | 0.125 | Toll-Like receptor 4 antagonist | 0.125 0.039 CID_26295 | CID_26295 | |
| 0.018 | 0.222 | 0.158 | Carbonic anhydrase V inhibitor | 0.158 0.013 CID_26295 | CID_26295 | |
| 0.013 | 0.218 | 0.092 | Mannosidase inhibitor | 0.092 0.007 CID_26295 | CID_26295 | |
| 0.035 | 0.242 | 0.077 | Histone deacetylase SIRT3 inhibitor | 0.077 0.02 CID_26295 | CID_26295 | |
| 0.003 | 0.21 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 CID_26295 | CID_26295 | |
| 0.011 | 0.218 | 0.077 | Aromatase inhibitor | 0.077 0.029 CID_26295 | CID_26295 | |
| 0.071 | 0.279 | 0.209 | Sphingosine 1-phosphate receptor 2 antagonist | 0.209 0.006 CID_26295 | CID_26295 | |
| 0.027 | 0.236 | 0.059 | CD45 antagonist | 0.059 0.022 CID_26295 | CID_26295 | |
| 0.006 | 0.217 | 0.06 | Prostacyclin antagonist | 0.06 0.01 CID_26295 | CID_26295 | |
| 0.02 | 0.233 | 0.143 | Sphingosine 1-phosphate receptor 4 agonist | 0.143 0.01 CID_26295 | CID_26295 | |
| 0.043 | 0.257 | 0.086 | MDM2 inhibitor | 0.086 0.014 CID_26295 | CID_26295 | |
| 0.041 | 0.255 | 0.105 | Vanilloid 4 agonist | 0.105 0.013 CID_26295 | CID_26295 | |
| 0.021 | 0.235 | 0.322 | Porphobilinogen synthase inhibitor | 0.322 0.005 CID_26295 | CID_26295 | |
| 0.163 | 0.378 | 0.433 | 5 Hydroxytryptamine release inhibitor | 0.433 0.06 CID_26295 | CID_26295 | |
| 0.007 | 0.222 | 0.031 | Geranylgeranyltransferase inhibitor | 0.031 0.009 CID_26295 | CID_26295 | |
| 0.01 | 0.226 | 0.067 | Dopamine D5 agonist | 0.067 0.009 CID_26295 | CID_26295 | |
| 0.044 | 0.262 | 0.131 | Proteasome inhibitor | 0.131 0.057 CID_26295 | CID_26295 | |
| 0.01 | 0.229 | 0.073 | Thromboxane A2 antagonist | 0.073 0.019 CID_26295 | CID_26295 | |
| 0.013 | 0.232 | 0.078 | Thromboxane antagonist | 0.078 0.021 CID_26295 | CID_26295 | |
| 0.005 | 0.226 | 0.024 | Kynurenine 3 monooxygenase inhibitor | 0.024 0.022 CID_26295 | CID_26295 | |
| 0.023 | 0.244 | 0.197 | Carbonic anhydrase XIII inhibitor | 0.197 0.014 CID_26295 | CID_26295 | |
| 0.1 | 0.322 | 0.479 | 5 Hydroxytryptamine release stimulant | 0.479 0.031 CID_26295 | CID_26295 | |
| 0.021 | 0.243 | 0.061 | CDC25B inhibitor | 0.061 0.049 CID_26295 | CID_26295 | |
| 0.044 | 0.267 | 0.125 | Lanosterol 14 alpha demethylase inhibitor | 0.125 0.026 CID_26295 | CID_26295 | |
| 0.037 | 0.26 | 0.218 | GABA C receptor agonist | 0.218 0.017 CID_26295 | CID_26295 | |
| 0.016 | 0.241 | 0.043 | Adenylate cyclase 1 inhibitor | 0.043 0.036 CID_26295 | CID_26295 | |
| 0.012 | 0.236 | 0.1 | Liver X receptor agonist | 0.1 0.007 CID_26295 | CID_26295 | |
| 0.044 | 0.27 | 0.131 | Electrolyte absorption antagonist | 0.131 0.029 CID_26295 | CID_26295 | |
| 0.053 | 0.281 | 0.179 | Adenylate kinase inhibitor | 0.179 0.018 CID_26295 | CID_26295 | |
| 0.005 | 0.233 | 0.022 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.022 0.016 CID_26295 | CID_26295 | |
| 0.013 | 0.241 | 0.095 | Carbonic anhydrase XIV inhibitor | 0.095 0.012 CID_26295 | CID_26295 | |
| 0.041 | 0.27 | 0.19 | Mucolytic | 0.19 0.016 CID_26295 | CID_26295 | |
| 0.122 | 0.352 | 0.425 | GABA C receptor rho-3 antagonist | 0.425 0.051 CID_26295 | CID_26295 | |
| 0.018 | 0.248 | 0.082 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.082 0.015 CID_26295 | CID_26295 | |
| 0.098 | 0.33 | 0.286 | DNA synthesis inhibitor | 0.286 0.049 CID_26295 | CID_26295 | |
| 0.017 | 0.25 | 0.114 | Purinergic P2X2 antagonist | 0.114 0.023 CID_26295 | CID_26295 | |
| 0.03 | 0.264 | 0.12 | Glutamate dehydrogenase inhibitor | 0.12 0.023 CID_26295 | CID_26295 | |
| 0.014 | 0.248 | 0.096 | Argininosuccinate synthase inhibitor | 0.096 0.02 CID_26295 | CID_26295 | |
| 0.056 | 0.291 | 0.205 | Phospholipase A2 inhibitor | 0.205 0.04 CID_26295 | CID_26295 | |
| 0.037 | 0.273 | 0.187 | Alkylator | 0.187 0.03 CID_26295 | CID_26295 | |
| 0.02 | 0.257 | 0.136 | Sphingosine kinase 2 inhibitor | 0.136 0.004 CID_26295 | CID_26295 | |
| 0.01 | 0.247 | 0.027 | Glutamate (mGluR1) agonist | 0.027 0.013 CID_26295 | CID_26295 | |
| 0.071 | 0.309 | 0.254 | Non-steroidal antiinflammatory agent | 0.254 0.041 CID_26295 | CID_26295 | |
| 0.089 | 0.329 | 0.336 | 12-Lipoxygenase inhibitor | 0.336 0.062 CID_26295 | CID_26295 | |
| 0.002 | 0.242 | 0.012 | Imidazoline I2 receptor antagonist | 0.012 0.006 CID_26295 | CID_26295 | |
| 0.018 | 0.261 | 0.359 | Histidine decarboxylase inhibitor | 0.359 0.005 CID_26295 | CID_26295 | |
| 0.034 | 0.277 | 0.171 | Ferrochelatase inhibitor | 0.171 0.03 CID_26295 | CID_26295 | |
| 0.008 | 0.252 | 0.023 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.022 CID_26295 | CID_26295 | |
| 0.009 | 0.253 | 0.031 | Melatonin 2 agonist | 0.031 0.025 CID_26295 | CID_26295 | |
| 0.09 | 0.335 | 0.223 | Growth factor agonist | 0.223 0.045 CID_26295 | CID_26295 | |
| 0.028 | 0.275 | 0.179 | Expectorant | 0.179 0.025 CID_26295 | CID_26295 | |
| 0.005 | 0.252 | 0.022 | Imidazoline I1 receptor antagonist | 0.022 0.012 CID_26295 | CID_26295 | |
| 0.007 | 0.254 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 CID_26295 | CID_26295 | |
| 0.039 | 0.287 | 0.174 | Sodium channel (voltage-gated) blocker | 0.174 0.04 CID_26295 | CID_26295 | |
| 0.008 | 0.256 | 0.044 | Matrix metalloproteinase 1 inhibitor | 0.044 0.043 CID_26295 | CID_26295 | |
| 0.019 | 0.268 | 0.137 | Glutamate decarboxylase inhibitor | 0.137 0.016 CID_26295 | CID_26295 | |
| 0.005 | 0.255 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.015 CID_26295 | CID_26295 | |
| 0.026 | 0.276 | 0.179 | 5-Lipoxygenase inhibitor | 0.179 0.029 CID_26295 | CID_26295 | |
| 0.004 | 0.257 | 0.033 | Glutamate (mGluR2) antagonist | 0.033 0.017 CID_26295 | CID_26295 | |
| 0.102 | 0.355 | 0.277 | RNA-directed DNA polymerase inhibitor | 0.277 0.037 CID_26295 | CID_26295 | |
| 0.015 | 0.269 | 0.085 | Collagenase 3 inhibitor | 0.085 0.021 CID_26295 | CID_26295 | |
| 0.019 | 0.273 | 0.058 | Sphingosine 1-phosphate receptor 5 agonist | 0.058 0.028 CID_26295 | CID_26295 | |
| 0.022 | 0.279 | 0.092 | Metalloproteinase-2 inhibitor | 0.092 0.043 CID_26295 | CID_26295 | |
| 0.014 | 0.272 | 0.056 | Matrix metalloproteinase (membrane-type) inhibitor | 0.056 0.036 CID_26295 | CID_26295 | |
| 0.005 | 0.264 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.014 CID_26295 | CID_26295 | |
| 0.013 | 0.272 | 0.078 | Prostaglandin-E synthase inhibitor | 0.078 0.04 CID_26295 | CID_26295 | |
| 0.018 | 0.277 | 0.133 | Carbonic anhydrase VA inhibitor | 0.133 0.014 CID_26295 | CID_26295 | |
| 0.005 | 0.265 | 0.05 | Phosphoglycerate kinase inhibitor | 0.05 0.014 CID_26295 | CID_26295 | |
| 0.046 | 0.306 | 0.112 | D-Ala-D-Ala ligase inhibitor | 0.112 0.018 CID_26295 | CID_26295 | |
| 0.063 | 0.326 | 0.302 | Free radical scavenger | 0.302 0.051 CID_26295 | CID_26295 | |
| 0.013 | 0.276 | 0.07 | Sphingosine kinase 1 inhibitor | 0.07 0.006 CID_26295 | CID_26295 | |
| 0.015 | 0.279 | 0.071 | Matrix metalloproteinase inhibitor | 0.071 0.043 CID_26295 | CID_26295 | |
| 0.014 | 0.278 | 0.117 | Carbamoyl phosphate synthetase inhibitor | 0.117 0.016 CID_26295 | CID_26295 | |
| 0.005 | 0.27 | 0.05 | Glutamate (mGluR group II) antagonist | 0.05 0.016 CID_26295 | CID_26295 | |
| 0.078 | 0.342 | 0.164 | ATPase inhibitor | 0.164 0.08 CID_26295 | CID_26295 | |
| 0.01 | 0.276 | 0.047 | RNA-directed RNA polymerase inhibitor | 0.047 0.014 CID_26295 | CID_26295 | |
| 0.011 | 0.277 | 0.043 | Estrogen-related receptor gamma antagonist | 0.043 0.004 CID_26295 | CID_26295 | |
| 0.018 | 0.284 | 0.104 | Sphingosine kinase inhibitor | 0.104 0.007 CID_26295 | CID_26295 | |
| 0.021 | 0.288 | 0.091 | Metalloproteinase-9 inhibitor | 0.091 0.037 CID_26295 | CID_26295 | |
| 0.059 | 0.327 | 0.146 | P-glycoprotein inhibitor | 0.146 0.124 CID_26295 | CID_26295 | |
| 0.013 | 0.282 | 0.028 | Hedgehog signaling activator | 0.028 0.017 CID_26295 | CID_26295 | |
| 0.035 | 0.305 | 0.127 | Beta glucuronidase inhibitor | 0.127 0.039 CID_26295 | CID_26295 | |
| 0.017 | 0.288 | 0.036 | Vanilloid 3 antagonist | 0.036 0.033 CID_26295 | CID_26295 | |
| 0.004 | 0.275 | 0.022 | Hexokinase stimulant | 0.022 0.012 CID_26295 | CID_26295 | |
| 0.049 | 0.323 | 0.191 | Cell wall synthesis inhibitor | 0.191 0.034 CID_26295 | CID_26295 | |
| 0.011 | 0.286 | 0.05 | Dihydrofolate reductase inhibitor | 0.05 0.018 CID_26295 | CID_26295 | |
| 0.026 | 0.302 | 0.117 | Falcipain 3 inhibitor | 0.117 0.056 CID_26295 | CID_26295 | |
| 0.081 | 0.358 | 0.319 | Superoxide dismutase inhibitor | 0.319 0.044 CID_26295 | CID_26295 | |
| 0.036 | 0.314 | 0.141 | Thioredoxin inhibitor | 0.141 0.02 CID_26295 | CID_26295 | |
| 0.016 | 0.296 | 0.159 | Phenylalanine 4-hydroxylase inhibitor | 0.159 0.01 CID_26295 | CID_26295 | |
| 0.005 | 0.287 | 0.034 | Beta 1 adrenoreceptor agonist | 0.034 0.006 CID_26295 | CID_26295 | |
| 0.02 | 0.302 | 0.064 | NMDA receptor agonist | 0.064 0.042 CID_26295 | CID_26295 | |
| 0.013 | 0.296 | 0.052 | Plasmepsin II inhibitor | 0.052 0.016 CID_26295 | CID_26295 | |
| 0.011 | 0.296 | 0.072 | NMDA receptor glycine site agonist | 0.072 0.035 CID_26295 | CID_26295 | |
| 0.005 | 0.29 | 0.048 | Ribonucleoside-diphosphate reductase inhibitor | 0.048 0.042 CID_26295 | CID_26295 | |
| 0.02 | 0.305 | 0.055 | Botulinum neurotoxin type A inhibitor | 0.055 0.047 CID_26295 | CID_26295 | |
| 0.103 | 0.39 | 0.275 | Antibacterial | 0.275 0.154 CID_26295 | CID_26295 | |
| 0.015 | 0.304 | 0.051 | Thromboxane synthase inhibitor | 0.051 0.047 CID_26295 | CID_26295 | |
| 0.011 | 0.3 | 0.145 | Alcohol oxidase inhibitor | 0.145 0.011 CID_26295 | CID_26295 | |
| 0.005 | 0.296 | 0.048 | Ribonucleotide reductase inhibitor | 0.048 0.044 CID_26295 | CID_26295 | |
| 0.018 | 0.31 | 0.071 | Epithelial sodium channel blocker | 0.071 0.017 CID_26295 | CID_26295 | |
| 0.046 | 0.339 | 0.179 | Nav1.2 sodium channel blocker | 0.179 0.043 CID_26295 | CID_26295 | |
| 0.005 | 0.299 | 0.04 | TRPM8 blocker | 0.04 0.024 CID_26295 | CID_26295 | |
| 0.034 | 0.33 | 0.207 | Protein-tyrosine phosphatase inhibitor | 0.207 0.044 CID_26295 | CID_26295 | |
| 0.007 | 0.303 | 0.047 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.047 0.011 CID_26295 | CID_26295 | |
| 0.049 | 0.346 | 0.143 | Histone deacetylase SIRT1 inhibitor | 0.143 0.068 CID_26295 | CID_26295 | |
| 0.019 | 0.317 | 0.089 | Aminopeptidase I inhibitor | 0.089 0.035 CID_26295 | CID_26295 | |
| 0.044 | 0.343 | 0.299 | Anesthetic general | 0.299 0.033 CID_26295 | CID_26295 | |
| 0.085 | 0.384 | 0.341 | Antithrombotic | 0.341 0.068 CID_26295 | CID_26295 | |
| 0.002 | 0.303 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 CID_26295 | CID_26295 | |
| 0.019 | 0.322 | 0.072 | Sphingosine 1-phosphate receptor 1 antagonist | 0.072 0.017 CID_26295 | CID_26295 | |
| 0.057 | 0.36 | 0.181 | Prostaglandin dehydrogenase inhibitor | 0.181 0.171 CID_26295 | CID_26295 | |
| 0.004 | 0.308 | 0.042 | HCV NS5B polymerase inhibitor | 0.042 0.013 CID_26295 | CID_26295 | |
| 0.053 | 0.359 | 0.585 | Aldehyde oxidase inhibitor | 0.585 0.021 CID_26295 | CID_26295 | |
| 0.026 | 0.333 | 0.066 | Ryanodine receptor antagonist | 0.066 0.024 CID_26295 | CID_26295 | |
| 0.014 | 0.321 | 0.131 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.131 0.01 CID_26295 | CID_26295 | |
| 0.002 | 0.313 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 CID_26295 | CID_26295 | |
| 0.004 | 0.316 | 0.035 | G protein-coupled receptor agonist | 0.035 0.029 CID_26295 | CID_26295 | |
| 0.034 | 0.349 | 0.146 | Nav1.3 sodium channel blocker | 0.146 0.051 CID_26295 | CID_26295 | |
| 0.012 | 0.327 | 0.097 | Amidase inhibitor | 0.097 0.026 CID_26295 | CID_26295 | |
| 0.115 | 0.432 | 0.214 | 5 Hydroxytryptamine 3E antagonist | 0.214 0.043 CID_26295 | CID_26295 | |
| 0.011 | 0.329 | 0.086 | Glutamate receptor agonist | 0.086 0.048 CID_26295 | CID_26295 | |
| 0.031 | 0.349 | 0.171 | Psychostimulant | 0.171 0.099 CID_26295 | CID_26295 | |
| 0.006 | 0.325 | 0.056 | Ornithine carbamoyltransferase inhibitor | 0.056 0.034 CID_26295 | CID_26295 | |
| 0.015 | 0.334 | 0.085 | Sphingosine 1-phosphate receptor 3 antagonist | 0.085 0.014 CID_26295 | CID_26295 | |
| 0.017 | 0.337 | 0.211 | Nav1.8 sodium channel blocker | 0.211 0.007 CID_26295 | CID_26295 | |
| 0.018 | 0.338 | 0.214 | MAO inhibitor | 0.214 0.037 CID_26295 | CID_26295 | |
| 0.025 | 0.348 | 0.134 | Aminopeptidase B inhibitor | 0.134 0.045 CID_26295 | CID_26295 | |
| 0.029 | 0.352 | 0.1 | Glutathione S-transferase inhibitor | 0.1 0.037 CID_26295 | CID_26295 | |
| 0.018 | 0.341 | 0.048 | Glutamate (mGluR group III) antagonist | 0.048 0.024 CID_26295 | CID_26295 | |
| 0.09 | 0.416 | 0.349 | Vasodilator, coronary | 0.349 0.055 CID_26295 | CID_26295 | |
| 0.019 | 0.346 | 0.053 | Autotaxin inhibitor | 0.053 0.036 CID_26295 | CID_26295 | |
| 0.049 | 0.378 | 0.132 | Thiol protease inhibitor | 0.132 0.092 CID_26295 | CID_26295 | |
| 0.05 | 0.381 | 0.268 | Hexokinase inhibitor | 0.268 0.014 CID_26295 | CID_26295 | |
| 0.108 | 0.441 | 0.416 | Interleukin 2 agonist | 0.416 0.023 CID_26295 | CID_26295 | |
| 0.083 | 0.416 | 0.426 | Vasodilator, peripheral | 0.426 0.047 CID_26295 | CID_26295 | |
| 0.008 | 0.343 | 0.174 | MAO B inhibitor | 0.174 0.03 CID_26295 | CID_26295 | |
| 0.054 | 0.39 | 0.158 | Vasodilator | 0.158 0.146 CID_26295 | CID_26295 | |
| 0.043 | 0.379 | 0.441 | Peroxidase inhibitor | 0.441 0.015 CID_26295 | CID_26295 | |
| 0.022 | 0.361 | 0.052 | Factor III inhibitor | 0.052 0.03 CID_26295 | CID_26295 | |
| 0.013 | 0.353 | 0.052 | Thymidine kinase inhibitor | 0.052 0.017 CID_26295 | CID_26295 | |
| 0.039 | 0.38 | 0.272 | Aldehyde dehydrogenase inhibitor | 0.272 0.015 CID_26295 | CID_26295 | |
| 0.024 | 0.366 | 0.106 | Sphingosine 1-phosphate receptor antagonist | 0.106 0.018 CID_26295 | CID_26295 | |
| 0.029 | 0.371 | 0.153 | Sodium channel blocker | 0.153 0.056 CID_26295 | CID_26295 | |
| 0.099 | 0.445 | 0.31 | Nitric-oxide synthase stimulant | 0.31 0.009 CID_26295 | CID_26295 | |
| 0.029 | 0.377 | 0.122 | Caspase 3 inhibitor | 0.122 0.057 CID_26295 | CID_26295 | |
| 0.01 | 0.36 | 0.066 | Adenosine deaminase inhibitor | 0.066 0.016 CID_26295 | CID_26295 | |
| 0.007 | 0.358 | 0.035 | Angiotensin II receptor antagonist | 0.035 0.022 CID_26295 | CID_26295 | |
| 0.008 | 0.36 | 0.069 | Glycine transporter 2 inhibitor | 0.069 0.021 CID_26295 | CID_26295 | |
| 0.042 | 0.395 | 0.278 | Spasmolytic | 0.278 0.079 CID_26295 | CID_26295 | |
| 0.066 | 0.42 | 0.283 | Transcription factor STAT3 inhibitor | 0.283 0.062 CID_26295 | CID_26295 | |
| 0.016 | 0.37 | 0.048 | Glutamate (mGluR4) antagonist | 0.048 0.023 CID_26295 | CID_26295 | |
| 0.004 | 0.359 | 0.097 | Oleamide hydrolase inhibitor | 0.097 0.009 CID_26295 | CID_26295 | |
| 0.023 | 0.378 | 0.177 | Creatine kinase inhibitor | 0.177 0.015 CID_26295 | CID_26295 | |
| 0.01 | 0.366 | 0.028 | Complement factor 1s inhibitor | 0.028 0.011 CID_26295 | CID_26295 | |
| 0.054 | 0.41 | 0.171 | DNA repair enzyme inhibitor | 0.171 0.017 CID_26295 | CID_26295 | |
| 0.047 | 0.403 | 0.372 | Interleukin agonist | 0.372 0.024 CID_26295 | CID_26295 | |
| 0.005 | 0.362 | 0.046 | Angiotensin AT1 receptor antagonist | 0.046 0.023 CID_26295 | CID_26295 | |
| 0.021 | 0.378 | 0.122 | Mediator release inhibitor | 0.122 0.046 CID_26295 | CID_26295 | |
| 0.015 | 0.372 | 0.049 | Purinergic P2X4 antagonist | 0.049 0.026 CID_26295 | CID_26295 | |
| 0.028 | 0.387 | 0.099 | GABA B receptor agonist | 0.099 0.017 CID_26295 | CID_26295 | |
| 0.05 | 0.409 | 0.175 | GABA C receptor rho-2 antagonist | 0.175 0.046 CID_26295 | CID_26295 | |
| 0.006 | 0.365 | 0.026 | Acid ceramidase inhibitor | 0.026 0.017 CID_26295 | CID_26295 | |
| 0.014 | 0.374 | 0.077 | Lipase inhibitor | 0.077 0.047 CID_26295 | CID_26295 | |
| 0.014 | 0.381 | 0.041 | Aggrecanase 1 inhibitor | 0.041 0.024 CID_26295 | CID_26295 | |
| 0.011 | 0.38 | 0.04 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.015 CID_26295 | CID_26295 | |
| 0.007 | 0.378 | 0.069 | Prostaglandin antagonist | 0.069 0.027 CID_26295 | CID_26295 | |
| 0.008 | 0.38 | 0.077 | Acetylcholine M5 receptor agonist | 0.077 0.037 CID_26295 | CID_26295 | |
| 0.007 | 0.381 | 0.075 | Neutrophil collagenase inhibitor | 0.075 0.035 CID_26295 | CID_26295 | |
| 0.038 | 0.416 | 0.118 | Glutamate (mGluR7) agonist | 0.118 0.032 CID_26295 | CID_26295 | |
| 0.019 | 0.399 | 0.088 | Beta 2 adrenoreceptor agonist | 0.088 0.006 CID_26295 | CID_26295 | |
| 0.073 | 0.455 | 0.167 | Neurotensin receptor agonist | 0.167 0.066 CID_26295 | CID_26295 | |
| 0.006 | 0.389 | 0.038 | Lysophosphatidic acid 2 receptor antagonist | 0.038 0.014 CID_26295 | CID_26295 | |
| 0.002 | 0.385 | 0.025 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.025 0.022 CID_26295 | CID_26295 | |
| 0.024 | 0.41 | 0.136 | Interleukin 1 beta converting enzyme inhibitor | 0.136 0.024 CID_26295 | CID_26295 | |
| 0.063 | 0.452 | 0.227 | 15-Lipoxygenase inhibitor | 0.227 0.185 CID_26295 | CID_26295 | |
| 0.036 | 0.426 | 0.282 | Hypolipemic | 0.282 0.055 CID_26295 | CID_26295 | |
| 0.022 | 0.412 | 0.13 | GABA C receptor antagonist | 0.13 0.043 CID_26295 | CID_26295 | |
| 0.026 | 0.417 | 0.146 | Cytidine deaminase inhibitor | 0.146 0.078 CID_26295 | CID_26295 | |
| 0.034 | 0.426 | 0.241 | Mannose-6-phosphate isomerase inhibitor | 0.241 0.014 CID_26295 | CID_26295 | |
| 0.047 | 0.44 | 0.139 | Pregnane X receptor agonist | 0.139 0.077 CID_26295 | CID_26295 | |
| 0.009 | 0.405 | 0.066 | 5 Hydroxytryptamine 2A agonist | 0.066 0.041 CID_26295 | CID_26295 | |
| 0.004 | 0.403 | 0.03 | Glucagon receptor antagonist | 0.03 0.02 CID_26295 | CID_26295 | |
| 0.026 | 0.426 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.06 0.025 CID_26295 | CID_26295 | |
| 0.013 | 0.414 | 0.063 | Cytokine production stimulant | 0.063 0.011 CID_26295 | CID_26295 | |
| 0.015 | 0.417 | 0.091 | Beta adrenoreceptor antagonist | 0.091 0.021 CID_26295 | CID_26295 | |
| 0.004 | 0.407 | 0.05 | Diamine oxidase inhibitor | 0.05 0.015 CID_26295 | CID_26295 | |
| 0.009 | 0.413 | 0.034 | Integrin alpha2 antagonist | 0.034 0.031 CID_26295 | CID_26295 | |
| 0.019 | 0.425 | 0.085 | Interferon inducer | 0.085 0.02 CID_26295 | CID_26295 | |
| 0.023 | 0.431 | 0.165 | AMP-activated protein kinase stimulant | 0.165 0.02 CID_26295 | CID_26295 | |
| 0.021 | 0.432 | 0.079 | Somatostatin 1 agonist | 0.079 0.052 CID_26295 | CID_26295 | |
| 0.081 | 0.499 | 0.344 | Apoptosis antagonist | 0.344 0.059 CID_26295 | CID_26295 | |
| 0.048 | 0.468 | 0.188 | Cyclic AMP phosphodiesterase inhibitor | 0.188 0.103 CID_26295 | CID_26295 | |
| 0.004 | 0.427 | 0.047 | Geranyltranstransferase inhibitor | 0.047 0.027 CID_26295 | CID_26295 | |
| 0.03 | 0.458 | 0.131 | Acetylcholine release stimulant | 0.131 0.033 CID_26295 | CID_26295 | |
| 0.003 | 0.433 | 0.045 | Antimetabolite | 0.045 0.035 CID_26295 | CID_26295 | |
| 0.033 | 0.463 | 0.11 | Phosphodiesterase 6D inhibitor | 0.11 0.035 CID_26295 | CID_26295 | |
| 0.01 | 0.44 | 0.075 | Beta 1 adrenoreceptor antagonist | 0.075 0.022 CID_26295 | CID_26295 | |
| 0.04 | 0.472 | 0.293 | Alpha-glucosidase inhibitor | 0.293 0.163 CID_26295 | CID_26295 | |
| 0.025 | 0.459 | 0.111 | DNA directed RNA polymerase inhibitor | 0.111 0.044 CID_26295 | CID_26295 | |
| 0.003 | 0.438 | 0.045 | Urate transporter 1 inhibitor | 0.045 0.022 CID_26295 | CID_26295 | |
| 0.035 | 0.47 | 0.188 | DNA methyltransferase I inhibitor | 0.188 0.075 CID_26295 | CID_26295 | |
| 0.004 | 0.441 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.014 CID_26295 | CID_26295 | |
| 0.013 | 0.455 | 0.059 | Aryl hydrocarbon receptor antagonist | 0.059 0.056 CID_26295 | CID_26295 | |
| 0.028 | 0.472 | 0.143 | Nav1.4 sodium channel blocker | 0.143 0.037 CID_26295 | CID_26295 | |
| 0.029 | 0.473 | 0.146 | Adenylate cyclase inhibitor | 0.146 0.048 CID_26295 | CID_26295 | |
| 0.062 | 0.507 | 0.408 | Histamine release inhibitor | 0.408 0.071 CID_26295 | CID_26295 | |
| 0.008 | 0.455 | 0.08 | Histone deacetylase SIRT2 inhibitor | 0.08 0.045 CID_26295 | CID_26295 | |
| 0.012 | 0.459 | 0.062 | Lysine-specific demethylase 1A inhibitor | 0.062 0.026 CID_26295 | CID_26295 | |
| 0.036 | 0.484 | 0.15 | Platelet adhesion inhibitor | 0.15 0.106 CID_26295 | CID_26295 | |
| 0.025 | 0.475 | 0.133 | Nav1.5 sodium channel blocker | 0.133 0.04 CID_26295 | CID_26295 | |
| 0.015 | 0.467 | 0.104 | Interferon agonist | 0.104 0.026 CID_26295 | CID_26295 | |
| 0.009 | 0.462 | 0.148 | MAO A inhibitor | 0.148 0.042 CID_26295 | CID_26295 | |
| 0.006 | 0.464 | 0.028 | Thymidine phosphorylase inhibitor | 0.028 0.015 CID_26295 | CID_26295 | |
| 0.004 | 0.463 | 0.036 | Dihydropteroate synthase inhibitor | 0.036 0.033 CID_26295 | CID_26295 | |
| 0.012 | 0.472 | 0.062 | Beta adrenoreceptor agonist | 0.062 0.007 CID_26295 | CID_26295 | |
| 0.021 | 0.486 | 0.16 | Thrombolytic | 0.16 0.074 CID_26295 | CID_26295 | |
| 0.012 | 0.478 | 0.057 | Dopamine beta hydroxylase inhibitor | 0.057 0.019 CID_26295 | CID_26295 | |
| 0.028 | 0.498 | 0.11 | Interleukin 1b antagonist | 0.11 0.07 CID_26295 | CID_26295 | |
| 0.02 | 0.491 | 0.129 | Histone deacetylase class III inhibitor | 0.129 0.062 CID_26295 | CID_26295 | |
| 0.018 | 0.489 | 0.087 | Beta 3 adrenoreceptor antagonist | 0.087 0.019 CID_26295 | CID_26295 | |
| 0.02 | 0.492 | 0.19 | Lipid peroxidase inhibitor | 0.19 0.046 CID_26295 | CID_26295 | |
| 0.02 | 0.496 | 0.12 | GABA C receptor rho-1 antagonist | 0.12 0.04 CID_26295 | CID_26295 | |
| 0.039 | 0.517 | 0.214 | Thyroid hormone antagonist | 0.214 0.15 CID_26295 | CID_26295 | |
| 0.009 | 0.489 | 0.075 | Inducible nitric-oxide synthase inhibitor | 0.075 0.071 CID_26295 | CID_26295 | |
| 0.013 | 0.5 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.057 0.049 CID_26295 | CID_26295 | |
| 0.009 | 0.5 | 0.064 | Beta 2 adrenoreceptor antagonist | 0.064 0.02 CID_26295 | CID_26295 | |
| 0.019 | 0.511 | 0.125 | Uric acid excretion stimulant | 0.125 0.035 CID_26295 | CID_26295 | |
| 0.009 | 0.501 | 0.105 | Protein kinase C zeta inhibitor | 0.105 0.044 CID_26295 | CID_26295 | |
| 0.045 | 0.538 | 0.188 | Neuropeptide Y2 antagonist | 0.188 0.143 CID_26295 | CID_26295 | |
| 0.038 | 0.532 | 0.184 | Thyroid hormone beta antagonist | 0.184 0.169 CID_26295 | CID_26295 | |
| 0.015 | 0.519 | 0.122 | Myeloperoxidase inhibitor | 0.122 0.019 CID_26295 | CID_26295 | |
| 0.017 | 0.524 | 0.123 | Neurotrophic factor | 0.123 0.09 CID_26295 | CID_26295 | |
| 0.008 | 0.516 | 0.09 | Platelet activating factor alpha antagonist | 0.09 0.068 CID_26295 | CID_26295 | |
| 0.028 | 0.542 | 0.123 | Neuropeptide Y1 antagonist | 0.123 0.115 CID_26295 | CID_26295 | |
| 0.022 | 0.537 | 0.135 | Antibacterial (Helicobacter pylori) | 0.135 0.061 CID_26295 | CID_26295 | |
| 0.029 | 0.545 | 0.194 | DNA methylase inhibitor | 0.194 0.083 CID_26295 | CID_26295 | |
| 0.023 | 0.542 | 0.093 | MAP kinase kinase 7 inhibitor | 0.093 0.02 CID_26295 | CID_26295 | |
| 0.005 | 0.528 | 0.074 | Nav1.7 sodium channel blocker | 0.074 0.039 CID_26295 | CID_26295 | |
| 0.028 | 0.553 | 0.189 | Hemostatic | 0.189 0.037 CID_26295 | CID_26295 | |
| 0.013 | 0.538 | 0.092 | Glucosylceramidase inhibitor | 0.092 0.01 CID_26295 | CID_26295 | |
| 0.023 | 0.549 | 0.101 | mTOR complex 2 inhibitor | 0.101 0.031 CID_26295 | CID_26295 | |
| 0.054 | 0.581 | 0.232 | Insulysin inhibitor | 0.232 0.115 CID_26295 | CID_26295 | |
| 0.019 | 0.546 | 0.201 | Dual specificity phosphatase 3 inhibitor | 0.201 0.06 CID_26295 | CID_26295 | |
| 0.01 | 0.539 | 0.083 | Phosphodiesterase 3A inhibitor | 0.083 0.051 CID_26295 | CID_26295 | |
| 0.004 | 0.535 | 0.07 | Toll-Like receptor 8 antagonist | 0.07 0.024 CID_26295 | CID_26295 | |
| 0.016 | 0.548 | 0.129 | Alkaline phosphatase inhibitor | 0.129 0.077 CID_26295 | CID_26295 | |
| 0.025 | 0.561 | 0.159 | Cytokine production inhibitor | 0.159 0.056 CID_26295 | CID_26295 | |
| 0.013 | 0.557 | 0.116 | Cyclooxygenase 1 inhibitor | 0.116 0.085 CID_26295 | CID_26295 | |
| 0.026 | 0.572 | 0.187 | MAP3K9 inhibitor | 0.187 0.022 CID_26295 | CID_26295 | |
| 0.001 | 0.55 | 0.013 | Adenosine A2a receptor agonist | 0.013 0.012 CID_26295 | CID_26295 | |
| 0.012 | 0.561 | 0.052 | CC chemokine 4 receptor antagonist | 0.052 0.025 CID_26295 | CID_26295 | |
| 0.009 | 0.569 | 0.074 | Protein kinase C beta inhibitor | 0.074 0.04 CID_26295 | CID_26295 | |
| 0.005 | 0.565 | 0.102 | Phosphodiesterase IV inhibitor | 0.102 0.044 CID_26295 | CID_26295 | |
| 0.01 | 0.571 | 0.097 | Urease inhibitor | 0.097 0.071 CID_26295 | CID_26295 | |
| 0.009 | 0.572 | 0.103 | Alcohol dehydrogenase inhibitor | 0.103 0.049 CID_26295 | CID_26295 | |
| 0.056 | 0.621 | 0.302 | Caspase 3 stimulant | 0.302 0.078 CID_26295 | CID_26295 | |
| 0.002 | 0.57 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.013 CID_26295 | CID_26295 | |
| 0.021 | 0.593 | 0.094 | Thioredoxin reductase inhibitor | 0.094 0.035 CID_26295 | CID_26295 | |
| 0.011 | 0.584 | 0.126 | Mcl-1 antagonist | 0.126 0.118 CID_26295 | CID_26295 | |
| 0.019 | 0.592 | 0.172 | Dual specificity phosphatase inhibitor | 0.172 0.073 CID_26295 | CID_26295 | |
| 0.008 | 0.583 | 0.069 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.069 0.063 CID_26295 | CID_26295 | |
| 0.009 | 0.585 | 0.067 | Potassium channel (ATP-sensitive) blocker | 0.067 0.045 CID_26295 | CID_26295 | |
| 0.02 | 0.599 | 0.089 | Bromodomain-containing protein 2 inhibitor | 0.089 0.056 CID_26295 | CID_26295 | |
| 0.018 | 0.602 | 0.121 | Interleukin 8 antagonist | 0.121 0.061 CID_26295 | CID_26295 | |
| 0.01 | 0.594 | 0.06 | Cyclin D1 inhibitor | 0.06 0.043 CID_26295 | CID_26295 | |
| 0.01 | 0.595 | 0.082 | Caspase 7 inhibitor | 0.082 0.057 CID_26295 | CID_26295 | |
| 0.035 | 0.62 | 0.258 | Transcription factor STAT inhibitor | 0.258 0.081 CID_26295 | CID_26295 | |
| 0.032 | 0.622 | 0.185 | Tumour necrosis factor antagonist | 0.185 0.063 CID_26295 | CID_26295 | |
| 0.029 | 0.618 | 0.231 | DNA damaging | 0.231 0.092 CID_26295 | CID_26295 | |
| 0.023 | 0.623 | 0.134 | NADPH oxidase inhibitor | 0.134 0.067 CID_26295 | CID_26295 | |
| 0.015 | 0.619 | 0.115 | Bone formation stimulant | 0.115 0.09 CID_26295 | CID_26295 | |
| 0.01 | 0.619 | 0.158 | Aryl hydrocarbon receptor agonist | 0.158 0.129 CID_26295 | CID_26295 | |
| 0.011 | 0.621 | 0.097 | Beta amyloid protein antagonist | 0.097 0.094 CID_26295 | CID_26295 | |
| 0.028 | 0.643 | 0.184 | Histone acetyltransferase inhibitor | 0.184 0.094 CID_26295 | CID_26295 | |
| 0.026 | 0.645 | 0.279 | Hypoxia-inducible factor 1 alpha inhibitor | 0.279 0.077 CID_26295 | CID_26295 | |
| 0.009 | 0.63 | 0.137 | MAP kinase kinase 1 inhibitor | 0.137 0.022 CID_26295 | CID_26295 | |
| 0.005 | 0.634 | 0.044 | Stearoyl-CoA desaturase inhibitor | 0.044 0.03 CID_26295 | CID_26295 | |
| 0.035 | 0.668 | 0.152 | MAP kinase 3 inhibitor | 0.152 0.065 CID_26295 | CID_26295 | |
| 0.009 | 0.643 | 0.123 | Protein kinase C gamma inhibitor | 0.123 0.05 CID_26295 | CID_26295 | |
| 0.008 | 0.646 | 0.09 | Nitric-oxide synthase inhibitor | 0.09 0.078 CID_26295 | CID_26295 | |
| 0.012 | 0.663 | 0.167 | Toll-Like receptor antagonist | 0.167 0.045 CID_26295 | CID_26295 | |
| 0.012 | 0.667 | 0.065 | Phosphodiesterase 1C inhibitor | 0.065 0.037 CID_26295 | CID_26295 | |
| 0.005 | 0.666 | 0.163 | Adrenaline agonist | 0.163 0.012 CID_26295 | CID_26295 | |
| 0.013 | 0.681 | 0.054 | Phosphodiesterase 1B inhibitor | 0.054 0.052 CID_26295 | CID_26295 | |
| 0.018 | 0.69 | 0.144 | Amyloid beta aggregation inhibitor | 0.144 0.113 CID_26295 | CID_26295 | |
| 0.017 | 0.693 | 0.121 | Interleukin 1 antagonist | 0.121 0.088 CID_26295 | CID_26295 | |
| 0.004 | 0.683 | 0.06 | Phosphodiesterase 4A inhibitor | 0.06 0.03 CID_26295 | CID_26295 | |
| 0.011 | 0.69 | 0.169 | I kappa B kinase epsilon inhibitor | 0.169 0.101 CID_26295 | CID_26295 | |
| 0.015 | 0.697 | 0.081 | Phosphodiesterase I inhibitor | 0.081 0.075 CID_26295 | CID_26295 | |
| 0.028 | 0.711 | 0.128 | Interleukin 12 antagonist | 0.128 0.023 CID_26295 | CID_26295 | |
| 0.004 | 0.709 | 0.108 | Bruton tyrosine kinase inhibitor | 0.108 0.013 CID_26295 | CID_26295 | |
| 0.022 | 0.736 | 0.103 | Transcription factor STAT6 inhibitor | 0.103 0.1 CID_26295 | CID_26295 | |
| 0.028 | 0.75 | 0.376 | Apoptosis agonist | 0.376 0.126 CID_26295 | CID_26295 | |
| 0.006 | 0.729 | 0.101 | Gastric antisecretory | 0.101 0.064 CID_26295 | CID_26295 | |
| 0.006 | 0.739 | 0.114 | Topoisomerase I inhibitor | 0.114 0.059 CID_26295 | CID_26295 | |
| 0.006 | 0.75 | 0.13 | MAP kinase kinase inhibitor | 0.13 0.065 CID_26295 | CID_26295 | |
| 0.007 | 0.755 | 0.15 | MAP kinase kinase 2 inhibitor | 0.15 0.122 CID_26295 | CID_26295 | |
| 0.011 | 0.759 | 0.188 | Antiamyloidogenic | 0.188 0.108 CID_26295 | CID_26295 | |
| 0.02 | 0.775 | 0.062 | Prolactin release inhibitor | 0.062 0.043 CID_26295 | CID_26295 | |
| 0.008 | 0.78 | 0.108 | Chelator | 0.108 0.067 CID_26295 | CID_26295 | |
| 0.011 | 0.789 | 0.153 | Insulin secretagoues | 0.153 0.071 CID_26295 | CID_26295 | |
| 0.013 | 0.801 | 0.249 | Angiogenesis inhibitor | 0.249 0.124 CID_26295 | CID_26295 | |
| 0.034 | 0.869 | 0.143 | Cyclin-dependent kinase 3 inhibitor | 0.143 0.113 CID_26295 | CID_26295 | |
| 0.005 | 0.849 | 0.211 | Bronchodilator | 0.211 0.017 CID_26295 | CID_26295 | |
| 0.005 | 0.856 | 0.081 | Aminoacyl-tRNA synthetase inhibitor | 0.081 0.076 CID_26295 | CID_26295 | |
| 0.005 | 0.886 | 0.159 | Platelet aggregation inhibitor | 0.159 0.118 CID_26295 | CID_26295 | |
| 0.005 | 0.896 | 0.199 | Tumour necrosis factor alpha release inhibitor | 0.199 0.11 CID_26295 | CID_26295 | |
| 0.005 | 0.96 | 0.257 | Antiobesity | 0.257 0.15 CID_26295 | CID_26295 | |
| 0.005 | 0.976 | 0.185 | Immunomodulator | 0.185 0.182 CID_26295 | CID_26295 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |